Real Estate Sale, Including Osaka HQ, To Raise $347m For Takeda
Executive Summary
As part of efforts to raise cash to pay for its acquisition of Shire, Takeda will sell off selected real estate holdings in Japan, including its Osaka HQ, to a mystery buyer.
You may also be interested in...
Takeda Says Last Pre-Shire Quarter ‘Robust’, But Quiet On Divestments
Takeda saw continued growth for mainstay drugs in what it described as a ‘robust’ last quarter of reporting before the inclusion of Shire, with global blockbuster Entyvio leading the way, but gave away little new on widely anticipated post-deal divestments.
Deal Watch: Purdue Continues Move Away From Opioids With Alivio Deal
In its continuing efforts to diversify away from opioid pain drugs, Purdue partners on non-opioid program with Alivio. Rigel licenses Tavalisse rights in all indications go to Spain’s Grifols.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: another big deal in radiopharmaceuticals; BioNTech’s ADC pipeline; China CDMOs embrace uncertain future; at look at the rivals in MASH; and industry views on how AI might be transformative.